Adrenocortical carcinoma ultrasound: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Adrenocortical carcinoma}} | {{Adrenocortical carcinoma}} | ||
{{CMG}}; {{AE}} {{MAD}} | |||
==Overview== | ==Overview== | ||
==Key Ultrasound Findings in Adrenocortical carcinoma== | ==Key Ultrasound Findings in Adrenocortical carcinoma== | ||
Line 12: | Line 12: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 16:25, 25 September 2017
Adrenocortical carcinoma Microchapters |
Differentiating Adrenocortical carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Study |
Adrenocortical carcinoma ultrasound On the Web |
American Roentgen Ray Society Images of Adrenocortical carcinoma ultrasound |
Risk calculators and risk factors for Adrenocortical carcinoma ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohammed Abdelwahed M.D[2]
Overview
Key Ultrasound Findings in Adrenocortical carcinoma
- Intravascular ultrasound may complement other imaging studies to estimate the extent of tumor involvement.
- Intraoperative ultrasound may be used for metastatic deposits.